Entity form and cost-recovery settings for a medical products regulator

This Regulatory Impact Statement sets out the analysis produced to inform Cabinet decisions on entity form and cost-recovery settings for a medical products (medicines and medical devices) regulator.

Cabinet material and decisions relating to this Regulatory Impact Statement can be found at: Cabinet Material - Medical Products Bill: Reducing Regulation and Other Policy Matters.